Abstract
Development of stability indicating method for the simultaneous estimation of alogliptin and pioglitazone in bulk and tablet dosage form by reversed-phase ultra-performance liquid chromatography method
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have